STRs in panel
Prev Next

Growth failure in early childhood

Gene: NF1

Amber List (moderate evidence)

NF1 (neurofibromin 1)
EnsemblGeneIds (GRCh38): ENSG00000196712
EnsemblGeneIds (GRCh37): ENSG00000196712
OMIM: 613113, Gene2Phenotype
NF1 is in 34 panels

3 reviews

Catherine Snow (Genomics England)

After NHS Genomic Medicine Service consideration, the rating of this gene has not been changed and remains AMBER. The additional comments from GLH's is that this is as specialist test
Created: 31 Jan 2023, 5:28 p.m. | Last Modified: 31 Jan 2023, 5:28 p.m.
Panel Version: 2.33

Arina Puzriakova (Genomics England Curator)

Comment on list classification: Short stature is a variable feature of NF1-related Noonan syndrome but >3 unrelated individuals have been reported with height at least 3 SDS below the mean. Although from the literature it was not clear whether this degree of severity can be reached within the first two years of life. Therefore, flagging for GMS expert review by the Endocrine Specialist Group to reach consensus as to whether this gene is appropriate for inclusion.
Created: 5 Jan 2023, 5:27 p.m. | Last Modified: 5 Jan 2023, 5:27 p.m.
Panel Version: 2.17

Eleanor Williams (Genomics England Curator)

Review submitted on behalf of Helen Storr. Mode of inheritance: AD. Phenotypes: 15 RASopathy genes are already included in the panel. These cause a range of clinical features within the Noonan syndrome / overlapping RASopathy spectrum disorders. >80% children with NS have growth failure. It is a multi-system disorder with several other important features that need to be identified/screened for including cardiac disease, cancer susceptibility, developmental problems and learning difficulties. The panel needs to updated to reflect the expanding gene list causing RASopathies. Publications: Although RASopathy genes are included on this panel, this needs to be updated / expanded with more newly identified genes and in line with current guidance (recent review - Zenker et al, Arch Dis Child 2022). Mechansim: Dysregulation of RAS-MAPK pathway with concomitant impact on growth and GH signalling. Penetrance: Variable penetrance depending on the gene - some unclear.
Created: 22 Dec 2022, 11:07 a.m. | Last Modified: 22 Dec 2022, 11:07 a.m.
Panel Version: 2.5

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

History Filter Activity

2 Feb 2023, Gel status: 2

Removed Tag, Removed Tag

Achchuthan Shanmugasundram (Genomics England Curator)

Tag Q1_23_promote_green was removed from gene: NF1. Tag Q1_23_expert_review was removed from gene: NF1.

5 Jan 2023, Gel status: 2

Set publications

Arina Puzriakova (Genomics England Curator)

Publications for gene: NF1 were set to

5 Jan 2023, Gel status: 2

Set Phenotypes

Arina Puzriakova (Genomics England Curator)

Phenotypes for gene: NF1 were changed from to Neurofibromatosis-Noonan syndrome, OMIM:601321

5 Jan 2023, Gel status: 2

Added Tag, Added Tag

Arina Puzriakova (Genomics England Curator)

Tag Q1_23_promote_green tag was added to gene: NF1. Tag Q1_23_expert_review tag was added to gene: NF1.

5 Jan 2023, Gel status: 2

Entity classified by Genomics England curator

Arina Puzriakova (Genomics England Curator)

Gene: nf1 has been classified as Amber List (Moderate Evidence).

5 Jan 2023, Gel status: 1

Set mode of inheritance

Arina Puzriakova (Genomics England Curator)

Mode of inheritance for gene: NF1 was changed from to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

22 Dec 2022, Gel status: 1

Created, Added New Source, Set mode of inheritance

Eleanor Williams (Genomics England Curator)

gene: NF1 was added gene: NF1 was added to Growth failure in early childhood. Sources: Expert list Mode of inheritance for gene: NF1 was set to